항암제 Flashcards

1
Q

Hodgkin’s lymphoma 항암 치료 2가지

A

MOPP, ABVD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

MOPP

A

Mechlorethamine, vincristine(Oncovin), Procarbazine, Prednisone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

ABVD

A

Adriamycin(doxorubicin). Bleomycin, Vinblastine, Dacarbazine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Non-Hodgkin’s lymphoma

A

CHOP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is CHOP ?

A

Cyclophosphamide, Hydroxydaunorubicin(doxorubicin), vincristine(Oncovin), Prednisone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is acute lymphocytic leukemia combination drug?

A

POMP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

POMP?

A

Prednisone, Vincristine(Oncovin), Methotrexate, Purinethol(mercaptopurine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is colorectal cancer combination drug?

A

FolFox/Folfiri

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Defects in the mismatch repair enzyme family gives rise to resistance to unrelated anticancer agents, including the __________, __________, and ______________.

A

fluoropyrimidines, thiopurines, cisplatin/carboplatin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

hMSH2

A

mistmatch repair enzyme

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

methotrexate(MTX)

A

anticancer drug, antimetabolites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

5-Fluorouracil (5-FU)

A

anticancer drug, antimetabolites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Capecitabine

A

anticancer drug, antimetabolites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

6-Mercaptopurine(6-MP)

A

anticancer drug, antimetabolites(purine analogues)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

6-Thioguanine(6-TG)

A

anticancer drug, antimetabolites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Cytarabine

A

anticancer drug, antimetabolites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Gemcitabine

A

anticancer drug, antimetabolites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Paclitaxel은 cell cycle의 어떤 phase을 막나?

A

M phase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

vinca alkaloids인 vinblastine, vincristine, vinorelbine은 cell cycle의 어떤 phase을 막나?

A

M phase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

alkylating agents는 cell cycle의 어떤 phase에 붙너?

A

cell cycle-Nonspecific agents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

MTX MOA: binding with high affinity to the active catalytic site of __________, decreasing the synthesis of tetrahydrofolate(THF)

A

dihydrofolate reductase (DHFR)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

______________ is used in conjunction with high-dose MTX therapy to rescue normal cells from undue toxicity, and it has also been used in cases of accidental drug overdose.

A

Leucovorin rescue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

One of these metabolites, _________, forms a covalently ternary complex with the enzyme thymidlate synthase and the reduced folate 5,10-methylenetetrahydrofolate, a reaction critical for the de novo synthesis of thymidylate. This results in inhibition of DNA synthesis through “thyminelss death”.

A

FdUMP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

5-FU is converted to _____________, which is then incorporated into RNA, where it interferes with RNA processing and mRNA translation.

A

FUTP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
5-FU is also converted to _______________, which can be incorporated into cellular DNA, resulting in inhibition of DNA synthesis and function.
FdUTP
26
____________ is also used in combination with the chemotherapy agent 5-FU in treating colon cancer.
Leucovorin
27
________ enhances the effect of 5-FU by inhibiting thymidylate synthase.
Leucovorin
28
FOLFOX의 구성은?
FOLinic acid(Leucovorin)m 5-Fu, OXaliplatin
29
5-FU의 unique한 AE는?
hand-foot syndrome
30
_________ is used as a first-line treatment alone for pancreatic cancer.
Gemcitabine
31
6-MP의 항암효과를 높여주는 약물과 그 이유는?
allopurinol, XO inhibitor로서 6-MP의 작용을 높여줌, 따라서 같이 사용시 6-MP의 용량을 낮춰야함
32
___________, a potent xanthine oxidase inhibitor, is frequently used in the treatment of acute leukemias to prevent the development of hyperuricemia that often occurs with tumor cell lysis.
allopurinol
33
Both 6-MP and 6-TG are salvaged by the __________ of immune effector cells.
HPRT(hypoxanthine-guanine phosphoribosyltransferase)
34
Doxorubicin
anticancer drug, anthracycline, inhibition of topoisomerase 2
35
Daunorubicin
anticancer drug, Anthracycline
36
Daunorubicin, Doxorubicin, Idarubicin에서 주목해야할 delayed toxicity는?
Cardiotoxicity
37
The cardiotoxicity is associated with the free radical mechanism. Treatment with the iron-chelating agent _______________ is currently approved to prevent or reduce anthracycline-induced cardiotoxicity.
dexrazoxane
38
_____________ is dose-limiting for bleomycin and usually presents as peneumonitis with cough, dyspnea, dry inspiratory crackles on phsical examination, and infiltrates on chest x-ray.
Pulmonary toxicity
39
___________ acts by binding to DNA, which results in single-strand and double-strand breaks following free radical formation, and inhibitiono of DNA biosynthesis.
Bleomycin
40
Mitomycin C
anticancer drug, alkylating agent
41
_____________ , manifested as microangiopathic hemolytic anemia, thrombocytopenia, and renal failure, as well as occasional instances of interstitial pneumonitis have been reported.
Hemolytic-uremic syndrome
42
Cyclophosphamide
anticancer drug, (classical) alkylating agent
43
Mechlorethamine
anticancer drug, (classical) alkylating agent
44
Nitrosourea
anticancer drug, (classical) alkylating agent
45
procabazine
anticancer drug, (nonclassical) alkylating agent
46
Dacarbazine
anticancer drug, (nonclassical) alkylating agent
47
alopecia and hemoorhagic cystitis occasionally occur with ___________; cystitis can be prevented with adequate hydration. (물을 공급해서 빠르게 배출해내겠다, Acrolein을 해독시키는 해독제을 사용)
Cyclophosphamide
48
Cyclophosphamide에서 출혈성 방광염을 일으키는 물질(acrolein)을 해독시키는 해독제는?
Mesna
49
다음과 같은 특성을 지닌 약은? -one naturally occurring sugar-containing nitrosourea -minimal bone marrow toxicity -treatment of insulin-secreting islet cell carcinoma of pancreas
Streptozocin
50
___________ is administered parenterally(비경구적으로) and is used in the treatment of malignant melanoma, Hodgkin’s lymphoma, soft tisuue sarcomas, and neuroblastoma.
Dacarbazine//anticancer drug, (nonclassical) alkylating agent
51
다음과 같은 특성을 지닌 약은? -an imidazotetrazine derivative of decarbazine. -for the treatment of glioblastoma multiforme.(교모세포종)
Temozolomide
52
Cisplatin
anticancer drug, alkylating agent, Platinum analogs
53
Carboplatin
anticancer drug, alkylating agent, Platinum analogs
54
Oxaliplatin
anticancer drug, alkylating agent, Platinum analogs
55
• an imidazotetrazine derivative of dacarbazine. • for the treatment of glioblastoma multiforme
Temozolomide
56
*Tumors that are resistant to cisplatin or carboplatin on the basis of mismatch repair defects are not cross resistant to__________, and this finding may explain the activity of this platinum compound in colorectal cancer.
oxaliplatin
57
Paclitaxel and Docetaxel AE: Hypersensitivity reactions (up to 5% of patients) - associated with the solvent _______________.
Cremophor EL
58
A novel albumin-bound paclitaxel formulation, Less myelosuppression and neurotoxicity compared with paclitaxel.
Abraxane
59
- binds directly to b-tubulin subunits on microtubules, leading to inhibition of normal microtubule dynamics (a novel microtubule-stabilizing agent) -activity in drug-resistant tumors that overexpress P-glycoprotein or tubulin mutations.
Ixabepilone
60
A prodrug that is converted mainly in the liver by the carboxylesterase enzyme to the SN-38 metabolite, which is 1000-fold more potent. Inhibition of topoisomerase I.
Irinotecan
61
Inhibition of topoisomerase II, which results in DNA damage through strand breakage induced by the formation of a ternary complex of drug, DNA, and enzyme.
Etoposide
62
Hydrolysis of blood asparagine → ↓asparagine in tumor cells sed for the treatment of childhood acute lymphocytic leukemia in combination with vincristine, methotrexate, and prednisone. AE: Hepatotoxicity (due to ammonium toxicity)
L-Asparaginase
63
특정 세포에는 BCR-ABL kinase가 엄청나게 증가한 것을 확인하였고, 그것을 표적으로 하는 kinase inhibitor인 _________(상품명 glibec)을 개발하게 되었다
imatininb
64
an inhibitor of the tyrosine kinase domain of the Bcr-Abl oncoprotein → prevents phosphorylation of the kinase substrate by ATP. the treatment of chronic myelogenous leukemia (CML), a pluripotent hematopoietic stem cell disorder characterized by the t(9:22) Philadelphia chromosomal translocation.
Imatinib (GLEEVEC)
65
___________ overcome imatinib resistance resulting from mutations in the BCR-Abl kinase.
Dasatinib/Nilotinib
66
임상: non-small cell lung cancer(NSCLC) MOA: inhibits EGFR tyrosin kinase leading to inhibition of EGFR signaling
Gefitinib (IRESSA)
67
mAb that attaches to CD20 protein on B cells B cell의 성장을 억제
Rituximab (RITUXEN)
68
Her2: human epidermal growth factor receptor 2 breast cancer patient
Trastuzumab (HERCEPTIN)
69
a member of histone deacetylases (HDAC) inhibitors. the treatment of cutaneous T cell lymphoma (CTCL) when the disease persists, gets worse, or comes back during or after treatment with other medicines.
Vorinostat (ZOLINZA)
70
⚫ a chemical analogue of cytidine, a nucleoside present in DNA and RNA. ⚫ used in the treatment of myelodysplastic syndrome .
5-Azacitidine / Decitabine
71
___________acts as a false substrate and potent inhibitor of methyltransferases leading to reduction of DNA methylation — affecting the way cell regulation proteins are able to bind to the DNA/RNA substrate
Azacitidine
72
___________acts as a false substrate and potent inhibitor of methyltransferases leading to reduction of DNA methylation — affecting the way cell regulation proteins are able to bind to the DNA/RNA substrate
Azacitidine